US President Donald Trump has imposed a country-level tariff of 27 per cent on exports from India as part of his ‘Liberation ...

Pharmaceuticals, among other products, will not be subject to the reciprocal tariffs, according to a White House fact sheet ...

The US president announced a 27 per cent reciprocal tariff on India, claiming the South Asian country imposes a 52 per cent ...

President Trump has said tariffs on pharmaceutical and semiconductor imports will be announced shortly, as the US imposes a ...

The Trump administration's decision to exempt tariffs on Indian pharma imports brings relief to a $9 billion-plus US export ...

Shares of Indian pharma companies with significant US exposure surged by up to 14% after President Trump refrained from ...

India’s pharmaceutical industry has emerged as a notable exception in the recent US tariff announcements. Wanbury announced ...

US President says India imposes 52% tariff on American imports and engages in currency manipulation and non-tariff barriers ...

Shares of Indian pharmaceutical companies surged on Thursday after the US exempted the sector from new trade tariffs. The Nifty Pharma index rose by 2.3%, with major gains for IPCA Laboratories, Lupin ...

Of the $91 billion worth of India’s exports to the US, nearly $20 billion are expected to come under some form of exemption ...

Mumbai: Benchmark indices Sensex and Nifty closed down on Thursday due to selling in IT shares amid a global sell-off as US ...

Jefferies pointed out that India currently imposes up to 10% import duties on US drugs, with some having lower duties or ...